Fig. 1

Kaplan-Meier plots showing the cumulative incidence of patients achieving VLFEM among galcanezumab group (orange line), OMPM group (blue line), and overall (green line) over 6 months follow-up period

Abbreviation: OMPM: oral migraine preventive medication; VLFEM: very low-frequency episodic migraine